Signal-transducing adaptor family member-2 (STAP-2) is an adaptor protein that regulates various intracellular signaling pathways and promotes tumorigenesis in melanoma and breast cancer cells. However, the contribution of STAP-2 to the behavior of other types of cancer cells is unclear. Here, we show that STAP-2 promotes tumorigenesis of prostate cancer cells through up-regulation of EGF receptor (EGFR) signaling. Tumor growth of a prostate cancer cell line, DU145, was strongly decreased by STAP-2 knockdown. EGF-induced gene expression and phosphorylation of AKT, ERK, and STAT3 were significantly decreased in STAP-2-knockdown DU145 cells. Mechanistically, we found that STAP-2 interacted with EGFR and enhanced its stability by inhibiting c-...
AbstractEpidermal growth factor receptor (EGFR) is overexpressed in a variety of epithelial tumors a...
International audienceEGFR or ERBB2 contributes to prostate cancer (PCa) progression by activating t...
One growth factor receptor commonly altered during prostate tumor progression is the epidermal growt...
Signal-transducing adaptor family member-2 (STAP-2) is an adaptor protein that regulates various int...
Despite multiple reports of overexpression in prostate cancer (PC), the reliance of PC cells on acti...
Signal-transducing adaptor protein (STAP)-2 is a recently identified adaptor protein that contains P...
Abstract Background Metastatic Prostate cancer (PCa) cells have gained survival and invasive advanta...
Despite multiple reports of overexpression in prostate cancer (PC), the reliance of PC cells on acti...
The abnormal activation of the epidermal growth factor (EGF) pathway is one of the most common findi...
The transforming growth factor alpha-epidermal growth factor receptor (EGFR) autocrine pathway has b...
Prostate cancer stem-like cells (PCSCs) are being intensely investigated largely owing to their cont...
Activation of the EGF receptors EGFR (ErbB1) and HER2 (ErbB2) drives the progression of multiple can...
Six-transmembrane epithelial antigen of the prostate-2 (STEAP2) expression is increased in prostate ...
Epidermal growth factor receptor (EGFR) is overexpressed in a variety of epithelial tumors and is co...
Interference with the activation of growth factor recep-tors, specifically epidermal growth factor r...
AbstractEpidermal growth factor receptor (EGFR) is overexpressed in a variety of epithelial tumors a...
International audienceEGFR or ERBB2 contributes to prostate cancer (PCa) progression by activating t...
One growth factor receptor commonly altered during prostate tumor progression is the epidermal growt...
Signal-transducing adaptor family member-2 (STAP-2) is an adaptor protein that regulates various int...
Despite multiple reports of overexpression in prostate cancer (PC), the reliance of PC cells on acti...
Signal-transducing adaptor protein (STAP)-2 is a recently identified adaptor protein that contains P...
Abstract Background Metastatic Prostate cancer (PCa) cells have gained survival and invasive advanta...
Despite multiple reports of overexpression in prostate cancer (PC), the reliance of PC cells on acti...
The abnormal activation of the epidermal growth factor (EGF) pathway is one of the most common findi...
The transforming growth factor alpha-epidermal growth factor receptor (EGFR) autocrine pathway has b...
Prostate cancer stem-like cells (PCSCs) are being intensely investigated largely owing to their cont...
Activation of the EGF receptors EGFR (ErbB1) and HER2 (ErbB2) drives the progression of multiple can...
Six-transmembrane epithelial antigen of the prostate-2 (STEAP2) expression is increased in prostate ...
Epidermal growth factor receptor (EGFR) is overexpressed in a variety of epithelial tumors and is co...
Interference with the activation of growth factor recep-tors, specifically epidermal growth factor r...
AbstractEpidermal growth factor receptor (EGFR) is overexpressed in a variety of epithelial tumors a...
International audienceEGFR or ERBB2 contributes to prostate cancer (PCa) progression by activating t...
One growth factor receptor commonly altered during prostate tumor progression is the epidermal growt...